Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
- DOI
- 10.1007/s11095-022-03169-2
- Published
- 2022 Feb
- Container
- Pharmaceutical research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11095-022-03169-2,
title = {Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.},
author = {Kheshti AMS and Hajizadeh F and Barshidi A and Rashidi B and Ebrahimi F and Bahmanpour S and Karpisheh V and Noukabadi FK and Kiani FK and Hassannia H and Atyabi F and Kiaie SH and Kashanchi F and Navashenaq JG and Mohammadi H and Bagherifar R and Jafari R and Zolbanin NM and Jadidi-Niaragh F},
year = {2022},
journal = {Pharmaceutical research},
doi = {10.1007/s11095-022-03169-2},
url = {https://doi.org/10.1007/s11095-022-03169-2}
}RIS
TY - JOUR TI - Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. AU - Kheshti AMS AU - Hajizadeh F AU - Barshidi A AU - Rashidi B AU - Ebrahimi F AU - Bahmanpour S AU - Karpisheh V AU - Noukabadi FK AU - Kiani FK AU - Hassannia H AU - Atyabi F AU - Kiaie SH AU - Kashanchi F AU - Navashenaq JG AU - Mohammadi H AU - Bagherifar R AU - Jafari R AU - Zolbanin NM AU - Jadidi-Niaragh F PY - 2022 JO - Pharmaceutical research DO - 10.1007/s11095-022-03169-2 UR - https://doi.org/10.1007/s11095-022-03169-2 ER -
APA
AMS, K., F, H., A, B., B, R., F, E., S, B., V, K., FK, N., FK, K., H, H., F, A., SH, K., F, K., JG, N., H, M., R, B., R, J., NM, Z., & F, J. (2022). Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.. Pharmaceutical research. https://doi.org/10.1007/s11095-022-03169-2
Source records
- pubmed · retrieved 2026-09-25T11:27:58.287Z